OS Therapies Inc (OSTX) stock
OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.74−0.01 (-0.68%)
Close on Nov 13, 2026Market cap $34.36MP/E –Yield –
OS Therapies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
OS Therapies's ebitda for the twelve months ending Jun 30, 2026 was -$37.11M. For fiscal 2025 it was -$28.34M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$28.34M | – |
| FY2024 | Dec 31, 2024 | -$6.81M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$8.45M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.04M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.86M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.75M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.00M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.97M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.44M | – |
See a number that looks wrong?